On October 20th, the IECIE Indonesia Jakarta Vaping Expo was held at the Jakarta International Convention Center. The exhibition was expected to cover an area of 12,000 square meters, attract up to 10,000 visitors, and feature 300 exhibitors showcasing various brands.
As one of the exhibitors, Pinde Biotech's booth features a minimalist white theme with clear and prominent branding for their ODM and OEM businesses. According to the booth staff, Pinde's location is situated next to the main corridor of the exhibition hall, making it a prime spot for customers to pass by and take notice.
The staffers at Pinduoduo Frontline have announced that, to meet the demand of Southeast Asian audiences, Pinduoduo has customized large smoke e-cigarette products and low-priced pod-style e-cigarette products. Pinduoduo employees explain that, currently, the Southeast Asian market is primarily focused on pod vapes, but they will gradually follow the trends of other markets, such as the US and the Middle East. Therefore, they have brought the main products from the US and the Middle East to the Indonesian exhibition.
The staff of Pinduoduo have great confidence in the future of the Indonesian market. They state that Indonesia has a predominantly young population, and as a result, it may become the largest market in Southeast Asia. Moving forward, Pinduoduo plans to improve its corporate compliance work and continue to do business with a strong commitment to compliance.
To learn more about the IECIE Jakarta Vape Expo, click on the featured image to be redirected.
Statement:
This article is compiled from third-party information and is only intended for industry exchange and learning.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is intended only for industry-related discussions and research.
Due to limitations in translation ability, the translated article may not perfectly reflect the original text. Please consider the original text as the definitive source.
2FIRSTS upholds complete alignment with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign-related expressions and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
